Epidemiology of hepatitis A in Saudi Arabia: a retrospective analysis of Ministry of Health surveillance and yearbook data, 2006-2023

沙特阿拉伯甲型肝炎流行病学:2006-2023年卫生部监测和年鉴数据的回顾性分析

阅读:3

Abstract

BACKGROUND: This study investigates the epidemiology of hepatitis A virus (HAV) infection in Saudi Arabia from 2006 to 2023, focusing on temporal, demographic, and geographic variations in incidence. The aim was to characterize long-term national trends and identify high-risk subgroups to inform prevention strategies. METHODS: National HAV surveillance data were obtained from the Saudi Ministry of Health Statistical Yearbooks. Crude incidence rates (CIRs) were calculated using mid-year population estimates. Temporal trends were assessed via Joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC). Regional differences were analyzed with negative binomial regression using Riyadh as the reference. Group comparisons employed nonparametric tests, with statistical significance set at α=0.05. RESULTS: Between 2006 and 2023, 9,820 HAV cases were reported (mean 546/year). National CIR declined from 11.1 per 100,000 in 2006 to 0.48 in 2023, with an AAPC of -19.5% (95% CI -24.2 to -14.4; p < 0.001). Children aged 5-14 years bore the highest burden (53.5% of cases). Significant regional heterogeneity was observed, with persistently higher CIRs in Najran and Qurayyat, while urban centers showed lower, stable rates. Negative binomial regression identified higher adjusted risks in Qurayyat (IRR 2.89) and Najran (IRR 2.52). Saudis initially showed higher incidence than non-Saudis, but rates converged by 2023. Males consistently outnumbered females (ratio ∼1.6). CONCLUSION: HAV incidence in Saudi Arabia has markedly declined over the past two decades, reflecting improved sanitation and public health measures. This decline may, in part, reflect the impact of the national hepatitis A vaccination program introduced in 2008. However, age-, region-, and nationality-specific disparities remain, underscoring the need for geographically tailored interventions and consideration of targeted vaccination strategies to sustain progress and prevent resurgence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。